Chen Kangwei Appointed General Manager of AstraZeneca China Oncology Business Unit

On January 20, Leon Wang, Executive Vice President of AstraZeneca Global and President of International Business & China, along with Joe Fong, Senior Vice President of AstraZeneca Global in charge of the Asia region, announced to employees that, effective March 1, 2022, the current General Manager of AstraZeneca Taiwan, Kenny Chen, will be appointed as the General Manager of AstraZeneca China Oncology Business Unit. He will be fully responsible for AstraZeneca's oncology business in the China market and will be based in Shanghai.

It is reported that at the end of last month, Yin Min, the former head of AstraZeneca China Oncology Business Unit, officially left her position and subsequently joined BeiGene as the Chief Commercial Officer for Greater China.

Kangwei Chen graduated from the National University of Singapore with a background in health and medical affairs. After graduating from university, he worked as an Assistant Director at the Singapore Ministry of Health and also served as a Medical Officer at the Singapore General Hospital. In 2002, he joined Merck, where he held various positions including Director of Medical Affairs and Policy for Merck Singapore, Director of Clinical Research Operations for the Asia-Pacific region, Director of New Products and Oncology Business, Senior Marketing Director of Infectious Diseases Business for Merck China, Vice President, and Regional General Manager.

In 2013, Kangwei Chen left MSD, where he had worked for a decade, to join Bayer as the head of Bayer's specialty and general medicines markets in the Asia-Pacific region. Two years later, he joined AstraZeneca as the General Manager of AstraZeneca Philippines, achieving remarkable results. In February 2019, Kangwei Chen officially assumed the position of General Manager of AstraZeneca Taiwan, China.